STOCK TITAN

Organon executive converts 21,872 stock units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Organon & Co. (OGN) reported that its Head of Mfg & Supply, Juliana Papa Drinane, converted 21,872 restricted stock units into 21,872 common shares on November 13, 2026. Each RSU converts into one common share; her reported direct RSU balance afterward was 43,744.

On the same date, 7,492 common shares were delivered or withheld for payment of exercise price or tax liability, at a reported per-share price of $13.90. The units were part of 65,616 RSUs granted November 13, 2025, with one-third vesting each year and a final vesting date of November 13, 2028. No Rule 10b5-1 plan is reported.

Insider Drinane Juliana Papa
Role Head of Mfg & Supply
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F2 21,872 $0.00 $0.00
Exercise Common Stock 21,872 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 7,492 $13.90 $104K
Holdings After Transaction: Restricted Stock Units — 43,744 units (Direct); Common Stock — 35,238.703 shares (Direct)
Holdings Before and After: Restricted Stock Units, 65,616 to 43,744 units (Direct); Common Stock, 20,858.703 to 35,238.703 shares (Direct)
Footnotes (2)
  1. F1. Each Restricted Stock Unit ("RSU") converts into one share of Organon & Co. common stock.
  2. F2. 65,616 RSUs were granted on November 13, 2025, and one-third vest each year with the final vesting date being November 13, 2028.
Restricted stock units converted 21,872 RSUs Converted into 21,872 common shares on November 13, 2026.
Common shares acquired on conversion 21,872 shares Acquired through the RSU conversion on November 13, 2026.
Shares delivered or withheld 7,492 shares For payment of exercise price or tax liability on November 13, 2026.
Reported per-share price $13.90 per share Reported for the shares delivered or withheld on November 13, 2026.
RSUs after transaction 43,744 RSUs Direct RSU balance reported after the November 13, 2026 transaction.
RSUs granted 65,616 RSUs Granted November 13, 2025; one-third vest each year, with final vesting date November 13, 2028.
Restricted Stock Unit financial
"Each Restricted Stock Unit ("RSU") converts into one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Organon (OGN) Head of Mfg & Supply Juliana Papa Drinane report on November 13, 2026?

Juliana Papa Drinane converted 21,872 RSUs into 21,872 common shares and had 43,744 RSUs remaining. On the same date, 7,492 common shares were delivered or withheld for payment of exercise price or tax liability at a reported price of $13.90 per share. No Rule 10b5-1 plan is reported.

What is the vesting schedule for Organon (OGN) Head of Mfg & Supply Juliana Papa Drinane’s RSUs?

A grant of 65,616 RSUs was made on November 13, 2025; one-third vest each year, with the final vesting date on November 13, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Drinane Juliana Papa

(Last)(First)(Middle)
C/O ORGANON &CO.
30 HUDSON STREET, FLOOR 33

(Street)
JERSEY CITY NEW JERSEY 07302

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Head of Mfg & Supply
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/13/2026M21,872A$042,730.703D
Common Stock11/13/2026F7,492D$13.935,238.703D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)11/13/2026M21,872 (2) (2)Common Stock21,872$043,744D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") converts into one share of Organon & Co. common stock.
2. 65,616 RSUs were granted on November 13, 2025, and one-third vest each year with the final vesting date being November 13, 2028.
Remarks:
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading